Perioperative Outcome of Corticosteroids in Transforaminal Endoscopic Lumbar Discectomy
NCT ID: NCT03273036
Last Updated: 2017-09-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
30 participants
INTERVENTIONAL
2014-05-01
2015-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
NCT05058287
Epidural Steroid Following Discectomy for Herniated Disc Reduces Morbidity
NCT01499641
Evaluation of the Effectiveness of Transforaminal Epidural Injections in Lumbar Disc Herniation or Radiculitis
NCT01052571
CT Guided Injection for Low Back Radiculopathy: A Randomized Clinical Trial
NCT01267825
Subjective Intraoperative Use of Epidural Steroid Administration Following Discectomy
NCT04182997
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
epidural steroid injection
40 mg triamcinolone acetate 1 cc
40 mg Triamcinolone acetate 1 cc
40 mg Triamcinolone acetate 1 cc
placebo injection
no injection agent
Placebos
no injected agent
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
40 mg Triamcinolone acetate 1 cc
40 mg Triamcinolone acetate 1 cc
Placebos
no injected agent
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ramathibodi Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jatupon Kongtharvonskul
principle investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID 03-54-23
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.